Table 3.

Combined logistic regression analysis of the association between DNA repair and NQO1 genotype and the risk of AML

Repair genotypeDetoxification genotypeControlsPatients with AML3-150OR (95% CI)3-151P
XRCC1-399 NQO1-187     
 WT  WT 34 45 13-152 — 
 V  WT 71 60 0.64 (0.36-1.14) .13 
 WT  V 18 18 0.74 (0.33-1.66) .46 
 V  V 43 33 0.62 (0.32-1.18) .14 
XRCC3-241 NQO1-187     
 WT  WT 50 40 13-152 — 
 V  WT 53 57 1.47 (0.83-2.62) .19 
 WT  V 36 19 0.76 (0.37-1.56) .46 
 V  V 24 24 1.27 (0.62-2.63) .51 
Repair genotypeDetoxification genotypeControlsPatients with AML3-150OR (95% CI)3-151P
XRCC1-399 NQO1-187     
 WT  WT 34 45 13-152 — 
 V  WT 71 60 0.64 (0.36-1.14) .13 
 WT  V 18 18 0.74 (0.33-1.66) .46 
 V  V 43 33 0.62 (0.32-1.18) .14 
XRCC3-241 NQO1-187     
 WT  WT 50 40 13-152 — 
 V  WT 53 57 1.47 (0.83-2.62) .19 
 WT  V 36 19 0.76 (0.37-1.56) .46 
 V  V 24 24 1.27 (0.62-2.63) .51 

WT indicates wild-type genotype; V, presence of a variant allele (either heterozygous or homozygous).

F3-150

The AML group in this analysis included both de novo AML and t-AML cases.

F3-151

Adjusted for age.

F3-152

Used as the reference group.

or Create an Account

Close Modal
Close Modal